Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain

Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/JPR.S166617
P932PMC publication ID6134407
P698PubMed publication ID30233233

P50authorVincenzo ArcoraciQ47436348
Luigi CardiaQ61141495
Gioacchino CalapaiQ37368499
P2093author name stringCarmen Mannucci
Cristina Mondello
Epifanio Mondello
Martina Di Pietro
Raffaella Mallamace
Domenico Quattrone
Giuseppe Bova
Alessia A Barbagallo
P2860cites workAnterior lumbar interbody fusion for treatment of failed back surgery syndrome: an outcome analysisQ79792106
Failed back surgery syndromeQ83778363
Cannabis, Cannabinoids, and Sleep: a Review of the LiteratureQ39204199
Long-term outcome of patients treated with spinal cord stimulation for therapeutically refractory failed back surgery syndrome: a retrospective studyQ39259581
Cannabis use for chronic non-cancer pain: results of a prospective surveyQ39397282
The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 QuestionnaireQ39725622
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammationQ42053693
Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysisQ44197494
Mindfulness-based stress reduction for failed back surgery syndrome: a randomized controlled trial.Q48327875
The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population SurveyQ21710682
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesQ24623282
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trialsQ24625489
The orphan receptor GPR55 is a novel cannabinoid receptorQ24670137
Failed back surgery syndrome: current perspectivesQ28070035
Etiologies of failed back surgery syndromeQ28257647
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptorsQ28298326
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic reviewQ28300877
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideQ28362078
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvementQ28394506
Guidelines for the use of cannabinoid compounds in chronic painQ33225562
Surgery versus prolonged conservative treatment for sciatica.Q34004463
Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study).Q34029717
The evidence for pharmacological treatment of neuropathic painQ34130946
Agonistic properties of cannabidiol at 5-HT1a receptorsQ34463976
Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI).Q34709065
Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanismQ34714609
Failed back surgery syndrome - definition, epidemiology and demographicsQ36110581
Persistent postsurgical pain: risk factors and preventionQ36477806
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoidsQ36555572
Neurostimulation technology for the treatment of chronic pain: a focus on spinal cord stimulationQ36759518
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?Q38012845
Interventional pain management for failed back surgery syndromeQ38078503
Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?Q38383817
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled TrialsQ38386497
The endocannabinoid system and neuropathic painQ38702807
Neurological Aspects of Medical Use of CannabidiolQ38835253
Recent strategies for drug development in fibromyalgia syndromeQ38881756
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectcannabinoidsQ422936
P304page(s)1761-1767
P577publication date2018-01-01
P1433published inJournal of Pain ResearchQ6295704
P1476titleCannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain
P478volume11

Reverse relations

Q95270490A Balanced Approach for Cannabidiol Use in Chronic Paincites workP2860

Search more.